← Back to Clinical Trials
Recruiting NCT07204119

NCT07204119 Comparison of GT With TF Technique in Patient With Post-Operative Knee Stiffness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07204119
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Post-operative Knee Stiffness
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2025-02-12
Primary Completion 2025-12-15

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Tissue Flossing TechniqueGraston TechniqueControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2025-02-12 with a primary completion date of 2025-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study was to compare the effects of Graston Technique and Tissue Flossing Technique in patients with post-operative knee stiffness on pain, range of motion, and functional outcomes. A randomized controlled trial was conducted at Benazir Bhutto Hospital, Rawalpindi. The total sample size was 48, divided into three groups. The study duration was six months. Purposive sampling was applied for recruitment, and group randomization was performed by lottery method. Only patients with post-operative knee stiffness meeting the inclusion criteria were enrolled. Outcome measures included goniometer, Functional Independence Measure (FIM), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires. Data was collected at baseline and after interventions, and analysis was performed using SPSS version 23.

Eligibility Criteria

Inclusion Criteria: 1. Age group between 20 to 40 years. 2. Both male and female. 3. Patients with 6 weeks post-operative following open reduction and internal fixation (ORIF) of femur, tibia, or fibula shaft fracture 4. Decreased in knee Flexion \& Extension (A minimum of 20° or above). Exclusion criteria: 1. Those patients who have allergies to latex 2. Malignant or metabolic cause of knee fracture 3. Venous Thrombotic disease/ Varicose veins. 4. Cardiopulmonary illness and hypertension. 5. Skin diseases/ metabolic disorders. 6. Patient with arthroplasty and arthroscopy. 7. Patellar fracture/ ACL/ PCL/ MCL/ LCL rupture/ injuries. 8. Any pathological condition having effects on knees.

Contact & Investigator

Central Contact

imran amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Lal Gul Khan, MS

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07204119 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Post-operative Knee Stiffness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07204119 currently recruiting?

Yes, NCT07204119 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07204119 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT07204119 clinical trial?

NCT07204119 is sponsored by Riphah International University. The principal investigator is Lal Gul Khan, MS at Riphah International University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology